FindTrial
Sign In

Human GLP-1 agonist on Adiposity Distribution

Human GLP-1 agonist on Adiposity Distribution

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17013679
Enrollment
Unknown
Registered
2017-12-04
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Case series:Exenatide injection and Metformin

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1999 WHO Diabetes diagnosis criterion. BMI larger than 28kg/m2. Clinical feature of type 2 diabetes with relatively fine insulin and C-peptide level.

Exclusion criteria

Exclusion criteria: type 1 diabetes, malignant tumor, severe inflammation, hepatic or renal failure, cardiavascular attacks, hyper or hypothyroidism

Design outcomes

Primary

MeasureTime frame
adiposity distribution;blood sugar;—

Countries

China

Contacts

Public ContactSHI Bimin

The First Affiliated Hospital of Soochow University

shibimin@yeah.net+86 13862569825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026